SHIGAKEN. PHARM. IND. CO., LTD.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SHIGAKEN. PHARM. IND. CO., LTD. - overview
Established
1943
Location
-, Shiga, Japan
Primary Industry
Pharmaceuticals
About
Founded in 1943, and based in Japan, SHIGAKEN. PHARM. IND. CO.
, LTD. focuses on manufacturing pharmaceuticals and quasi-drugs. The company has maintained a consistent business strategy centered on production. The organization has completed 1 deal with the most recent occurring on December 24, 2024.
In December 2024, Nissha Co. , Ltd. agreed to acquire SHIGAKEN. PHARM.
IND. CO. , LTD. SHIGAKEN.
PHARM. IND. CO. , LTD.
is engaged in the manufacturing of pharmaceuticals and quasi-drugs, focusing on providing OEM (Original Equipment Manufacturer) services tailored to the needs of its clients. The company caters to a diverse clientele, including both domestic and international sales companies, allowing them to outsource the production of their health-related products. SHIGAKEN. PHARM.
IND. CO. , LTD. serves the healthcare sector, contributing to the development of a healthier society.
The company primarily markets its products within Japan and extends its reach to overseas markets, ensuring a broad customer base. SHIGAKEN. PHARM. IND.
CO. , LTD. generates revenue through B2B transactions with various clients seeking to outsource their pharmaceutical manufacturing needs. The company engages in contractual agreements with partners, where clients provide specifications for the products they require, and SHIGAKEN.
PHARM. IND. CO. , LTD.
executes the production process. This structure allows for partnerships that can adapt to the evolving requirements of the healthcare industry. Revenue is derived from contracts that may include costs associated with production runs and manufacturing processes tailored to individual client needs.
Current Investors
Nissha Co., Ltd.
Primary Industry
Pharmaceuticals
Sub Industries
Outsourcing, Pharmaceutical Research & Development
Website
www.shigaken-pharm.co.jp
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
SHIGAKEN. PHARM. IND. CO., LTD. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LP Direct | Completed | SHIGAKEN. PHARM. IND. CO., LTD. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.